Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate.

Lars Fåhraeus, L Fåhraeus, Adam Sydsjö, A Sydsjö, Lars Wallentin, L Wallentin
Fertility and Sterility · 1986 · vol. 45(4) , pp. 503–6 · PMID:2937657 · W2417668877
article OA: closed CC0 ⤵ 12 in-corpus citations
View on OpenAlex View on PubMed

Abstract

Ten women with endometriosis were treated with medroxyprogesterone acetate (MPA), 150 mg intramuscularly every second week. After 2 weeks, there was a significant (8%) decrease in the high-density lipoprotein (HDL) concentration. This reduction became more pronounced after 8 and 24 weeks' medication. The HDL reduction was confined to the HDL2 subfraction, which was decreased by 15%, 33%, and 58% after 2, 8, and 24 weeks, respectively; there was no significant change in the HDL3 concentration. During treatment, there was a continuous increase in the mean MPA plasma level and a strong inverse correlation between this level and the mean HDL and HDL2 cholesterol concentrations. It was concluded that MPA affects HDL metabolism in a dose-dependent way and in the same direction as other progestins.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Lipoproteins Medroxyprogesterone Pelvic Neoplasms Adult Cholesterol, HDL Cholesterol, HDL Delayed-Action Preparations Endometriosis Endometriosis Female Humans Lipoproteins Medroxyprogesterone Medroxyprogesterone Medroxyprogesterone Medroxyprogesterone Acetate Pelvic Neoplasms Pelvic Neoplasms Phospholipids

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (15)

Cited by (12)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:09:40.384591+00:00
License: CC0 · commercial use OK